Preferred Bank Q4 EPS $2.71 Beats $2.57 Estimate

Preferred Bank (NASDAQ:PFBC) reported quarterly earnings of $2.71 per share which beat the analyst consensus estimate of $2.57 by 5.45 percent. This is a 50.56 percent increase over earnings of $1.80 per share from the

byBenzinga Newsdesk

January 18, 2023

1 minute read

Vaxcyte Doses First Participants In Phase 2 Portion Of Ongoing VAX-24 Phase 1/2 Clinical Proof-Of-Concept Study In Adults

By Bill Haddad

Today, 3:49 AM

-- Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee Recommends Study Proceed as Planned -- -- Company Expects to Announce Topline Results from Both the Phase 1

PCVX

Acer Therapeutics’ Stock Down As FDA Rejects Inborn Metabolism Disorder (UCD) Candidate

By Ragothaman Srinivasan

Today, 3:49 AM

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to Acer Therapeutics’ (NASDAQ: ACER) New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for oral suspension in the treatment of patients with urea cycle disorders (UCDs).

ACER